# Eco-friendly RP-HPLC determination of bambuterol hydrochloride and montelukast sodium in tablet dosage with dissolution analysis

**Authors:** Manal Ibrahim, Nesrin K. Ramadan, Magda M. Ibrahim, Shereen A. Boltia

PMC · DOI: 10.1038/s41598-026-41125-x · 2026-03-22

## TL;DR

This paper presents a greener and validated HPLC method for determining two drugs in tablets, with a focus on reducing solvent hazards.

## Contribution

A novel eco-friendly RP-HPLC method with reduced solvent hazard for simultaneous drug analysis in tablets.

## Key findings

- The method showed linearity for bambuterol hydrochloride and montelukast sodium in specified concentration ranges.
- Mean recoveries of 100.92% and 99.39% were achieved for the two drugs in tablet dosage forms.
- The method demonstrated improved greenness and sustainability compared to existing procedures.

## Abstract

A simple, eco-friendly, and precise isocratic RP-HPLC method was developed and validated for the simultaneous determination of bambuterol hydrochloride (BBL) and montelukast sodium (MTK). Separation was performed on an Inertsil C18 column (250 × 4.6 mm, 5 μm) using ethanol/0.025 M phosphate buffer (pH 3.0) at 70:30 (v/v) on an Agilent 1200 Infinity II system. The method complied with ICH criteria and showed linearity over 1.20–100.00 µg mL⁻¹ (BBL) and 5.00–100.00 µg mL⁻¹ (MTK). Application to a combined tablet dosage form yielded mean recoveries of 100.92 ± 1.08% (BBL) and 99.39 ± 1.41% (MTK). Dissolution profiling was performed in 900 mL of 0.5% sodium lauryl sulfate medium. Method greenness and sustainability were benchmarked against a reported procedure using multiple tools, Analytical Eco-Scale, MoGAPI, AGREE, RGB-12, D-CHEMS-1, GEAR, CaFRI, CACI, and BAGI demonstrating a safer solvent profile via ethanol/buffer. Notably, the separation time is longer (≈ 16 min), indicating a deliberate trade-off between reduced solvent hazard and throughput; analytical performance was maintained. Overall, the method offers a robust, greener alternative for routine assay and dissolution testing of BBL and MTK in pharmaceuticals.

The online version contains supplementary material available at 10.1038/s41598-026-41125-x.

## Linked entities

- **Chemicals:** bambuterol hydrochloride (PubChem CID 54765), montelukast sodium (PubChem CID 23663996), ethanol (PubChem CID 702), sodium lauryl sulfate (PubChem CID 3423265)

## Full-text entities

- **Genes:** ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}
- **Diseases:** toxicity (MESH:D064420), inflammatory (MESH:D007249), asthma (MESH:D001249)
- **Chemicals:** Ethanol (MESH:D000431), Carbon (MESH:D002244), CHEMS-1 (-), ACN (MESH:C084683), TCA (MESH:D014238), silanol (MESH:C082343), SLS (MESH:D012967), O-phosphoric acid (MESH:C030242), MTK (MESH:C093875), methanol (MESH:D000432), phosphate (MESH:D010710), potassium dihydrogen phosphate (MESH:C013216), acetonitrile (MESH:C032159), BBL (MESH:C047766), terbutaline (MESH:D013726), water (MESH:D014867), CO2 (MESH:D002245)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13009499/full.md

---
Source: https://tomesphere.com/paper/PMC13009499